Related Experiment Video
Updated: Aug 10, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Mutant p53 proteins behave in a dominant, negative fashion in vivo
M Hachiya1, A Chumakov, C W Miller
1Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine 90048.
Abstract:
The p53 encodes a cellular phosphoprotein that has been association with both neoplastic transformation and the control of cellular growth. Recent studies have reported that p53 also acts as a transcriptional regulator. We have studied transactivational properties of human wild-type and mutant p53 proteins representing 4 major mutational hotspots (codons 141, 175, 248, 273) as well as a double mutant Tyr141/His273 and a p53 with the transcriptional activating region removed (pcDC2). Transactivation by p53 was shown with a p53 concensus binding sequence controlled CAT reporter gene, and activity was assayed after co-transfection of the reporter with either wild-type or mutant p53 expression constructs. Wild-type p53 as well as one mutant p53 [(mutation of arginine to histidine at codon 273 (His 273)], had strong transactivating activity, but all other mutant p53s were inactive in transcriptional activation, including the double mutant Tyr141/His273 suggesting that the Tyr141 mutation was dominant over the His273 mutation in the same protein. Moreover, when mutant p53 (Tyr141, His175, Trp248, or Tyr141/His273) was cotransfected with either wild-type p53 or mutant His273 p53, these mutants inhibited the transactivation of coexpressed wild-type p53. The p53 vector (pcDC2), which contains p53 oligomerization sequences, but not the transactivational domain, markedly inhibited wild-type p53 transactivational activity. Each of the mutant p53s similarly inhibited the transactivation of His273 p53. Therefore, with the exception of His273, each of the other mutant p53 were unable to transactivate and each behaved in a dominant negative fashion.
Insights
Wild-type p53 and a specific His273 mutant show transcriptional activity. Other p53 mutants, including a double mutant, are inactive and inhibit wild-type p53 function, acting in a dominant-negative manner.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The p53 protein is a cellular phosphoprotein linked to cancer and cell growth control.
- Emerging research indicates p53 also functions as a transcriptional regulator.
Purpose of the Study:
- To investigate the transactivational properties of wild-type and mutant human p53 proteins.
- To analyze p53 mutants at major mutational hotspots and their impact on transcriptional activity.
Main Methods:
- Co-transfection of a p53 consensus binding sequence-controlled CAT reporter gene with wild-type or mutant p53 expression constructs.
- Assaying transactivation activity of various p53 constructs, including single mutants, a double mutant, and a p53 variant lacking the transactivation domain.
Main Results:
- Wild-type p53 and the His273 mutant exhibited strong transactivating activity.
- Mutations at codons 141, 175, and 248, as well as the Tyr141/His273 double mutant, were transcriptionally inactive.
- Inactive p53 mutants inhibited the transactivation activity of wild-type p53 and the His273 mutant in a dominant-negative manner.
Conclusions:
- Human p53 acts as a transcriptional regulator.
- Most p53 mutants studied are transcriptionally inactive and exert dominant-negative effects on wild-type p53.
- The Tyr141 mutation appears dominant over the His273 mutation in a double mutant context.
Related Concept Videos
Negative Regulator Molecules
In-vitro Mutagenesis
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

